scholarly journals Methodological aspects for accelerometer-based assessment of physical activity in heart failure and health

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Fabian Schwendinger ◽  
Jonathan Wagner ◽  
Denis Infanger ◽  
Arno Schmidt-Trucksäss ◽  
Raphael Knaier

Abstract Background For valid accelerometer-assessed physical activity (PA) data, several methodological aspects should be considered. We aimed to 1) visualize the applicability of absolute accelerometer cut-offs to classify PA intensity, 2) verify recommendations to measure PA over 7 days by examining inter-day variability and reactivity, 3) examine seasonal differences in PA, and 4) recommend during which 10 h day period accelerometers should be worn to capture the most PA in patients with heart failure (HEART) and healthy individuals (HEALTH). Methods Fifty-six HEART (23% female; mean age 66 ± 13 years) and 299 HEALTH (51% female; mean age 54 ± 19 years) of the COmPLETE study wore accelerometers for 14 days. Aim 1 was analyzed descriptively. Key analyses were performed using linear mixed models. Results The results yielded poor applicability of absolute cut-offs. The day of the week significantly affected PA in both groups. PA-reactivity was not present in either group. A seasonal influence on PA was only found in HEALTH. Large inter-individual variability in PA timing was present. Conclusions Our data indicated that absolute cut-offs foster inaccuracies in both populations. In HEART, Sunday and four other days included in the analyses seem sufficient to estimate PA and the consideration of seasonal differences and reactivity seems not necessary. For healthy individuals, both weekend days plus four other days should be integrated into the analyses and seasonal differences should be considered. Due to substantial inter-individual variability in PA timing, accelerometers should be worn throughout waking time. These findings may improve future PA assessment. Trial registration The COmPLETE study was registered at clinicaltrials.gov (NCT03986892).

Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
Colin G Stirrat ◽  
Sowmya Venkatasubramanian ◽  
Tania Pawade ◽  
Andrew Mitchell ◽  
Anoop Shah ◽  
...  

Introduction: Urocortin 2 (UCN 2) and urocortin 3 (UCN 3) are endogenous peptide hormones with an emerging role in the pathophysiology and treatment of heart failure. For the first time, we examined the systemic cardiovascular effects of both UCN 2 and UCN 3 in healthy volunteers and patients with heart failure. Methods: Seven healthy volunteers (Group A) and nine patients with stable chronic heart failure (Group B, New York Heart Association class II and III, left ventricular ejection fraction <35%) on optimal medical therapy underwent non-invasive oscillometric sphygmomanometry and impedance cardiography during incremental intravenous infusions of sodium nitroprusside (0.15/0.5/1.5 μg/kg/min), UCN 2 (0.16/0.48/1.6 μg/min), UCN 3 (5/15/50 μg/min) and saline placebo in a randomised double blind two-way cross over study. Results: Other than diastolic blood pressure (78 vs 72 mmHg for Group A and B respectively, p<0.05), haemodynamic variables were similar at baseline of each infusion and were unchanged by saline placebo infusion (p>0.05 for all). SNP, UCN2 and UCN 3 infusions increased heart rate and cardiac index, and reduced systolic and diastolic blood pressure and peripheral vascular resistance index (PVRI) in both healthy volunteers and patients with heart failure (p<0.05 for all; see Figure 1). There were no significant differences in the changes in cardiac index or PVRI between healthy volunteers and patients with heart failure during either UCN 2 or UCN 3 infusions (p>0.05). Conclusion: Intravenous UCN 2 and especially UCN 3 increase cardiac output and reduce peripheral vascular resistance. This favourable haemodynamic profile suggests that UCN 2 and UCN 3 hold exciting therapeutic potential for the treatment of acute heart failure.


2020 ◽  
Vol 15 (3) ◽  
pp. 1-3
Author(s):  
Sarah Jane Palmer

In this monthly feature, Sarah Jane Palmer delves into topical news, the latest research and what the experts are saying on subjects related to cardiology and cardiac nursing practice.


Heart & Lung ◽  
2019 ◽  
Vol 48 (5) ◽  
pp. 381-385 ◽  
Author(s):  
Leonie Klompstra ◽  
Tiny Jaarsma ◽  
Anna Strömberg ◽  
Martje H.L. van der Wal

2014 ◽  
Vol 29 (4) ◽  
pp. 324-331 ◽  
Author(s):  
Hui-Chin Chien ◽  
Hsing-Mei Chen ◽  
Martin Garet ◽  
Ruey-Hsia Wang

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Michitaka Kato ◽  
Shintaro Ono ◽  
Hiromasa Seko ◽  
Toshiya Tsukamoto ◽  
Yasunari Kurita ◽  
...  

Heart & Lung ◽  
2019 ◽  
Vol 48 (6) ◽  
pp. 575
Author(s):  
Afshin Amirpour ◽  
Reihaneh Zavar ◽  
Javad Shahabi

Sign in / Sign up

Export Citation Format

Share Document